Dr Reddys Laboratories experienced a notable surge in trading volume during today's session, with the stock price increasing by 0.69% to Rs 1215.40. The increased activity has drawn attention to the stock, which is part of both the NIFTY 50 and NIFTY 100 indices.
During today's trade, Dr Reddys Laboratories shares have shown positive movement amid high volume, which clearly reflect investor's activity in the stock. As of May 9, 2025, sentiment analysis from Moneycontrol suggests a bearish outlook on the stock.
Financial Performance
An overview of Dr Reddys Laboratories' financial performance reveals consistent growth in revenue and net profit over the past few years.
Quarterly Results:
The company's quarterly performance shows a steady increase in both revenue and net profit:
| Year | Revenue (Cr) | Net Profit (Cr) | EPS |
|---|---|---|---|
| Mar 2024 | 7,113.80 | 1,306.30 | 78.66 |
| Jun 2024 | 7,696.10 | 1,386.50 | 83.61 |
| Sep 2024 | 8,038.20 | 1,335.80 | 80.45 |
| Dec 2024 | 8,381.20 | 1,400.00 | 16.97 |
| Mar 2025 | 8,528.40 | 1,581.20 | 19.12 |
Annual Results:
The annual financial data indicates consistent growth from 2021 to 2025:
| Year | Revenue (Cr) | Net Profit (Cr) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | 19,047.50 | 1,903.60 | 117.67 | 1,060.20 | 11.06 | 0.15 |
| 2022 | 21,545.20 | 2,112.20 | 131.57 | 1,154.59 | 11.35 | 0.16 |
| 2023 | 24,669.70 | 4,470.30 | 271.47 | 1,397.73 | 19.35 | 0.05 |
| 2024 | 28,011.10 | 5,563.20 | 335.22 | 1,693.93 | 19.74 | 0.06 |
| 2025 | 32,643.90 | 5,703.50 | 64.22 | 402.27 | 16.85 | 0.12 |
Additional Financial Details:
Key financial figures from the annual income statement (in crores):
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | 32,643 | 28,011 | 24,669 | 21,545 | 19,047 |
| Other Income | 1,097 | 894 | 1,055 | 484 | 291 |
| Total Income | 33,741 | 28,905 | 25,725 | 22,029 | 19,338 |
| Total Expenditure | 25,800 | 21,548 | 19,570 | 18,942 | 16,406 |
| EBIT | 7,940 | 7,357 | 6,154 | 3,086 | 2,932 |
| Interest | 282 | 171 | 142 | 95 | 97 |
| Tax | 1,954 | 1,623 | 1,541 | 878 | 931 |
| Net Profit | 5,703 | 5,563 | 4,470 | 2,112 | 1,903 |
Dr Reddys Laboratories' cash flow from operating activities has generally increased over the years, reaching Rs 4,642 crore in March 2025. The company's total assets have also grown, standing at Rs 49,426 crore as of March 2025. Dr Reddys Laboratories shares experienced notable trading activity, with the price currently at Rs 1215.40, reflecting a 0.69% increase during today's session.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
